ライフサイエンスコーパス: erythematous

1 ma, rheumatoid arthritis, and systemic lupus erythematous.

2 cally, the gingival papillary overgrowth was erythematous and edematous, with a propensity toward spo

3 Nine of them had infiltrated itchy erythematous and vesiculous plaques at the injection sit

4 All nine cats developed raised, erythematous areas at the site of inoculation within 72

5 Skin lesions with pruritic vesicles on an erythematous base with surrounding swelling and edema we

6 teristic lesions with central pearly hue and erythematous border were seen.

7 The incidence of erythematous candidiasis (EC), pseudomembranous candidia

8 Cutaneous Lupus Erythematous (CLE) is an autoimmune disease in which pat

9 d therapy, neutrophilia, and abrupt onset of erythematous cutaneous lesions.

10 ating, maculopapular, papulopustular, and/or erythematous diffuse rash.

11 of trauma and scar formation presented with erythematous, dry plaques with fine crackling involving

12 Twenty-four hours after injection, erythematous, elevated plaques were observed in all huma

13 hosis nigricans, carcinoid syndrome, unusual erythematous eruptions such as erythema gyratum repens,

14 patients who present with other, more common erythematous eruptions.

15 -17C in KCs develop well-demarcated areas of erythematous, flakey involved skin adjacent to areas of

16 leukemic conversion and with worsening of an erythematous generalized papular rash, he received one d

17 A 33-year-old woman presented with an erythematous gingival mass involving the anterior maxill

18 Patients with subacute and Discoid Lupus Erythematous had elevated Interferon score, about a thir

19 nful, black, crusted ulcer with a peripheral erythematous halo was noted in the left popliteal fossa;

20 -week-old male who presented with a swollen, erythematous left index finger and elevated serum marker

21 (r = 0.985; P = .006) but not urticarial and erythematous lesions (r = 0.632; P = .23).

22 Skin biopsy of the erythematous lesions showed dense neutrophilic infiltrat

23 P180 NC16A IgE antibodies with urticarial or erythematous lesions was observed (r = 0.481; P = .31),

24 erized by a spectrum of changes ranging from erythematous maculae to vascular tumors, by the presence

25 d is frequently associated with an overlying erythematous, macular rash that, together with the myalg

26 , followed by the development of one or more erythematous maculopapular lesions that evolve over the

27 nonhematologic toxicity consisted of grade 3 erythematous maculopapular rash observed in one patient

28 Two patients developed erythematous, maculopapular to papular eruptions confine

29 ith a history of EDS type III presented with erythematous mucogingival lesions.

30 k, thighs, and buttocks and multiple raised, erythematous nodules on both shins.

31 evealed multifocal lesions that consisted of erythematous nodules on the leg and foot in case 1 and s

32 A 21-year-old man presented with multiple erythematous nonfollicular papules partially confluent t

33 Class 2 mobility of tooth #28 along with an erythematous, papillary appearance of the lingual gingiv

34 ossa; the ulcer had begun as an asymptomatic erythematous papule 1 week previously.

35 0%]) had a clinical morphology consisting of erythematous papules with scale in a variety of distribu

36 py as multiple ulcers, polypoidal growth and erythematous patches and has shown to share clinicopatho

37 lesions in 90 (78%), polypoidal in 29 (25%), erythematous patches in 3 (2.5%) and petechial spots in

38 ated with the occurrence of rapidly changing erythematous patches with prominent, circinate, or gyrat

39 Skin biopsy of an erythematous plaque on the thigh demonstrated a suppurat

40 is a self-limited condition, manifesting as erythematous plaques or nodules after cold exposure, tha

41 The BP IgE-induced erythematous plaques were reminiscent of those clinicall

42 matic episodic flares of annular, polycyclic erythematous plaques with scale, which coalesce to invol

43 Erythematous plaques, 0.5 to 2.5 cm in diameter, were pr

44 y skin disease characterized by wet, oozing, erythematous, pruritic lesions in the acute stage and xe

45 therapy for chronic back pain who developed erythematous, purpuric plaques at the site of ice-pack a

46 He also developed a maculopapular and erythematous rash in the groin, genitalia, and buttocks.

47 ber and December 2011, a persistent, raised, erythematous rash in the tattoo area developed in 19 per

48 t, became lymphocytopenic, and developed the erythematous rash typical of CDV.

49 enia, decreased activity, conjunctivitis, an erythematous rash typical of distemper, CNS signs, and v

50 Erythematous rashes that are suggestive of early Lyme di

51 sis rubra pilaris (PRP) refers to a group of erythematous, scaling dermatologic conditions that have

52 g inflammatory skin disease characterized by erythematous scaly plaques.

53 ntermittent bouts of annular and polycyclic, erythematous, scaly plaques on the trunk and proximal ex

54 The lesions were erythematous, scaly, and crusted, always affecting the s

55 Such manifestations become erythematous-scaly as the condition progresses to the su

56 e criteria for diagnosis are (1) presence of erythematous-scaly, exudative, and crusted lesions invol

57 ations between: (1) oral mucosal disease and erythematous skin disease, (2) salivary gland dysfunctio

58 -cell-driven disorder characterized by thick erythematous skin plaques.

59 shortened life spans, prominent scaling and erythematous skin with alopecia, and occasional papillom

60 Patients with systemic lupus erythematous (SLE) display dysregulated B cell responses

61 ti-RNA autoantibodies both in systemic lupus erythematous (SLE) patients and in murine models of lupu

62 ost serious manifestations of systemic lupus erythematous (SLE).

63 sely associated with CLE than Systemic Lupus Erythematous (SLE).

64 Both had erythematous to cyanotic and hyperplastic gingiva.

65 The clinical manifestations include erythematous to purpuric plaques with a livedolike appea